HomeFileStructural heart disease

Structural heart disease

TAVR and Anticoagulation: Direct Anticoagulant Agents or Vitamin K Inhibitors?

In some patients, using an anticoagulant agent is not an option, it is just prescribed. Based on...

Thrombotic and Bleeding Risk after TAVR: Quick Tips to Stay Up to Date

Transcatheter aortic valve replacement (TAVR) is an increasingly frequent option for patients with severe aortic stenosis across...

AMULET vs. WATCHMAN: Appendage Closure Devices, Head to Head

This research was designed to compare the double closure system of the AMULET device with the WATCHMAN...

SOLACI-CACI 2021 | Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease

✔️ Watch again the session "Current & Immediate Future Role of Imaging in Structural and Coronary Heart...

SAPIEN 3 Ultra: Lower Incidence of Paravalvular Regurgitation?

Paravalvular regurgitation after transcatheter aortic valve replacement (TAVR) have historically been associated with worse clinical outcomes. Even...

SOLACI-CACI 2021 | SAC-FAC Session

✔️ Watch again the complete SAC-FAC Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: - SESSION I:...

SOLACI-CACI 2021 | PICS-AICS Session

✔️ Watch the PICS-AICS session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 02:07 - Initial Experience with...

SOLACI-CACI 2021 | EuroPCR Session

✔️ Watch the complete PCR in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 👉 How to manage Coronary...